Deaths Associated With Platelet Glycoprotein IIb/IIIa Inhibitor Treatment

Heart
doi 10.1136/heart.89.5.535
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Platelet Inhibition After Glycoprotein IIb/IIIa Inhibitor Therapy

Circulation
Cardiovascular MedicinePhysiologyCardiology
2001English

Platelet Inhibition With an Antibody to Glycoprotein IIb/IIIa

Circulation
Cardiovascular MedicinePhysiologyCardiology
1989English

Current Role of Platelet Glycoprotein IIb/IIIa Inhibitors in Acute Coronary Syndromes

JAMA - Journal of the American Medical Association
Medicine
2000English

Glycoprotein IIb/IIIa Induced Coronary Thrombolysis

Heart
2002English

Role of Platelet Membrane Glycoprotein IIb-IIIa in Agonist-Induced Tyrosine Phosphorylation of Platelet Proteins

Journal of Cell Biology
MedicineCell Biology
1990English

Platelet Glycoprotein IIb/IIIa Inhibition and Atheroembolism During Bypass Graft Angioplasty: A Cup Half Full

Circulation
Cardiovascular MedicinePhysiologyCardiology
2002English

Platelet Glycoprotein IIb/IIIa Receptor Blockade Improves Vascular Nitric Oxide Bioavailability in Patients With Coronary Artery Disease

Circulation
Cardiovascular MedicinePhysiologyCardiology
2003English

Platelet Glycoprotein IIb/IIIa Inhibitors Reduce Mortality in Diabetic Patients With Non–ST-Segment Elevation Acute Coronary Syndromes

ACC Current Journal Review
2002English

Cost-Effectiveness of Platelet Glycoprotein IIb/IIIa Inhibition With Eptifibatide in Patients With Non-St-Elevation Acute Coronary Syndromes

Circulation
Cardiovascular MedicinePhysiologyCardiology
2000English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy